Pernix Therapeutics Holdings Reports Third Quarter 2011 Financial Results - MarketWatch (press release)
Tuesday, November 15th, 2011Pernix Therapeutics Holdings Reports Third Quarter 2011 Financial Results MarketWatch (press release) Natroba(TM) received US Food and Drug Administration (FDA) approval in January 2011 as a prescription medication indicated for the topical treatment of head lice infestations in patients four years of age and older. Natroba(TM) treats head lice using ... |